ImageneBio (IMA) EBIT Margin Growth (1y) (2021 - 2024)
ImageneBio (IMA) EBIT Margin Growth (1y) (2021 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | -1,651.00 |
| 10 | ImageneBio | 48.35 Mn | -87.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 158,765.00 |
| Dec 31, 2023 | -304,711.00 |
| Sep 30, 2023 | -136,660.00 |
| Jun 30, 2023 | 456,190.00 |
| Mar 31, 2023 | 20,922.00 |
| Dec 31, 2022 | -29,113.00 |
| Sep 30, 2022 | 10,844.00 |
| Jun 30, 2022 | -512,707.00 |
| Mar 31, 2022 | -22,145.00 |
| Dec 31, 2021 | 4.01 Mn |
| Sep 30, 2021 | -16,734.00 |
| Jun 30, 2021 | -19,285.00 |
| Mar 31, 2021 | -5,742.00 |